Cancer Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Transfusion Medicine
"What Triggers the Initiative of Developments in Transfusion Medicine: Advances in Ex Vivo Haemopoietic Cell Therapy and Next Generation Transfusion Products."
November 20th, 1995
According to an abstract submitted by the author to the 20th International Symposium on Blood Transfusion, entitled Trigger Factors in Transfusion Medicine, held October 4-6, 1995, in Groningen, The Netherlands, "Transfusion medicine and blood banking have evolved from the use of whole blood to plasma, red cell and platelet components, and now to mononuclear cell apheresis products for haemopoietic stem cell transplantations. Cultured or modified cells may represent the next transfusion product to support future cell therapies. The use of blood mononuclear cells has been driven by stem cell transplantation and an associated dramatic reduction in platelet recovery time and consequently...
Source: Cancer Weekly (1995-11-20)
|
|
Advertisement |
|
|
